[go: up one dir, main page]

WO2004085683A3 - Procede de diagnostic precoce de carcinomes, et necessaire pour la mise en oeuvre de ce procede - Google Patents

Procede de diagnostic precoce de carcinomes, et necessaire pour la mise en oeuvre de ce procede Download PDF

Info

Publication number
WO2004085683A3
WO2004085683A3 PCT/EP2004/003044 EP2004003044W WO2004085683A3 WO 2004085683 A3 WO2004085683 A3 WO 2004085683A3 EP 2004003044 W EP2004003044 W EP 2004003044W WO 2004085683 A3 WO2004085683 A3 WO 2004085683A3
Authority
WO
WIPO (PCT)
Prior art keywords
carrying
test kit
early carcinoma
carcinoma detection
papilloma virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/003044
Other languages
German (de)
English (en)
Other versions
WO2004085683A2 (fr
Inventor
Ralf Hilfrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BUCHNER ERWIN
Original Assignee
BUCHNER ERWIN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BUCHNER ERWIN filed Critical BUCHNER ERWIN
Priority to EP04722574A priority Critical patent/EP1656561A2/fr
Priority to JP2006504811A priority patent/JP2006521104A/ja
Publication of WO2004085683A2 publication Critical patent/WO2004085683A2/fr
Publication of WO2004085683A3 publication Critical patent/WO2004085683A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne un procédé de diagnostic précoce de carcinomes ou de leurs précurseurs provoqués par des papillomavirus humains ou bien présentant une association avec des papillomavirus humains, le diagnostic étant établi sur la base d'échantillons corporels. Selon ledit procédé, on détermine si une protéine virale des papillomavirus humains est exprimée. Cette protéine virale est une protéine capside, en particulier la protéine capside majeure L1. L'invention concerne en outre un nécessaire pour la mise en oeuvre dudit procédé.
PCT/EP2004/003044 2003-03-25 2004-03-23 Procede de diagnostic precoce de carcinomes, et necessaire pour la mise en oeuvre de ce procede Ceased WO2004085683A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP04722574A EP1656561A2 (fr) 2003-03-25 2004-03-23 Procede de diagnostic precoce de carcinomes, et necessaire pour la mise en oeuvre de ce procede
JP2006504811A JP2006521104A (ja) 2003-03-25 2004-03-23 癌腫の早期診断法及びこれを行うための検査キット

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10313388 2003-03-25
DE10313388.7 2003-03-25

Publications (2)

Publication Number Publication Date
WO2004085683A2 WO2004085683A2 (fr) 2004-10-07
WO2004085683A3 true WO2004085683A3 (fr) 2005-01-06

Family

ID=33038757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/003044 Ceased WO2004085683A2 (fr) 2003-03-25 2004-03-23 Procede de diagnostic precoce de carcinomes, et necessaire pour la mise en oeuvre de ce procede

Country Status (3)

Country Link
EP (1) EP1656561A2 (fr)
JP (1) JP2006521104A (fr)
WO (1) WO2004085683A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8916342B2 (en) 2006-11-13 2014-12-23 Oncohealth Corp. Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1936379A1 (fr) * 2006-12-21 2008-06-25 BUCHNER, Erwin Procédé pour la détection d'une infection active au HPV dans des échantillons biologiques par un dosage immunoenzymatique de type sandwich et nécessaire d'essai pour réaliser le procédé
WO2009059325A2 (fr) * 2007-11-02 2009-05-07 The Johns Hopkins University Compositions de peptide hpv multitype et procédés de traitement ou de prévention d'une infection par papillomavirus humain

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332596A1 (de) * 1993-09-24 1995-03-30 Martin Josef Dr Sapp Monoklonale Antikörper
US5985610A (en) * 1992-09-03 1999-11-16 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
US6165471A (en) * 1997-07-03 2000-12-26 University Of Colorado, University Technology Corporation Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
WO2003020975A2 (fr) * 2001-08-31 2003-03-13 Norchip A/S Oligonucleotides utilises pour detecter l'arnm du gène l1 des papillomavirus humains

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985610A (en) * 1992-09-03 1999-11-16 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE4332596A1 (de) * 1993-09-24 1995-03-30 Martin Josef Dr Sapp Monoklonale Antikörper
US6165471A (en) * 1997-07-03 2000-12-26 University Of Colorado, University Technology Corporation Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
WO2003020975A2 (fr) * 2001-08-31 2003-03-13 Norchip A/S Oligonucleotides utilises pour detecter l'arnm du gène l1 des papillomavirus humains

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MCMURRAY H R ET AL: "Biology of human papillomaviruses", INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, vol. 82, no. 1, February 2001 (2001-02-01), pages 15 - 33, XP002301425, ISSN: 0959-9673 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916342B2 (en) 2006-11-13 2014-12-23 Oncohealth Corp. Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8865162B2 (en) 2008-06-13 2014-10-21 Oncohealth Corp. Monoclonal antibodies against HPV proteins
US9568474B2 (en) 2008-06-13 2017-02-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US9128094B2 (en) 2010-01-08 2015-09-08 Oncohealth Corp. High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers

Also Published As

Publication number Publication date
EP1656561A2 (fr) 2006-05-17
WO2004085683A2 (fr) 2004-10-07
JP2006521104A (ja) 2006-09-21

Similar Documents

Publication Publication Date Title
TW200512457A (en) Method of diagnosing SARS corona virus infection
EP1381864A4 (fr) Detection du candida
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
AU2001278452A1 (en) Method for the detection of influenza a/b viruses
ATE540319T1 (de) Verfahren für die bestimmung von fk506
PT1190257E (pt) Deteccao precoce dos flavivirus, utilizando a glicoproteina ns1
EP2272988A3 (fr) Procédé de détection de mRNA du papillomavirus
WO2003100429A3 (fr) Diagnostic de carcinome hepatocellulaire
WO2004111081A3 (fr) Peptides antigeniques de coronavirus de sars, et utilisations
WO2005016132A3 (fr) Diagnostic pour le virus du sras
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2004016586A3 (fr) Compositions et methodes associees aux antigenes de domaine iii de la proteine d'enveloppe du flavivirus
WO2004085683A3 (fr) Procede de diagnostic precoce de carcinomes, et necessaire pour la mise en oeuvre de ce procede
WO2007006031A3 (fr) Trousses d'essai de diagnostic
WO2002021133A3 (fr) Procedes de detection du cancer fondes sur la prostasine
DE69621837D1 (de) Methoden zur feststellung von alzheimerscher krankheit
WO2002075308A3 (fr) Trousse et procede pour detecter des allergies alimentaires
WO2001056456A3 (fr) Procedes et compositions permettant de detecter une maladie
WO2002090989A3 (fr) Procede permettant de detecter des antigenes de globules sanguins et des anticorps diriges contre ces antigenes
DE50107569D1 (de) Nachweis von humanen papillomviren
WO2004032599A3 (fr) Nouvelles proteines immunogenes de leptospira
SE0202897D0 (sv) Method and kit for quantitative and qualitative determination of human papillomavirus
WO2006004958A3 (fr) Detection ou mesure d'anticorps par rapport a proteines antigenes dans des tissus ou des echantillons biologiques
ATE292800T1 (de) Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
WO2002092767A3 (fr) Detection d'arnm de synthase gd2 et utilisations correspondantes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006504811

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004722574

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004722574

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004722574

Country of ref document: EP